Quarterly Results

TONIRA PHARMA LTD.

NSE : NABSE : 530155ISIN CODE : INE844F01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE19.750 (0 %)
PREV CLOSE ( ) 19.75
OPEN PRICE ( ) 19.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 19.75 (1641)
VOLUME 1831
TODAY'S LOW / HIGH ( )19.00 19.90
52 WK LOW / HIGH ( ) 1919.9
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2011
Sep 2011
Jun 2011
Mar 2011
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
124.09
73.47
97.61
40.39
Total Expenditure
114.23
70.63
96.22
53.14
PBIDT (Excl OI)
9.86
2.84
1.39
-12.75
Other Income
6.3
1.32
0.00
5.82
Operating Profit
16.16
4.16
1.39
-6.93
Interest
8.64
5
9.1
7.64
Exceptional Items
NA
NA
0.00
6.1
PBDT
7.52
-0.84
-7.71
-8.47
Depreciation
5.75
8.17
8.08
3.31
Profit Before Tax
1.77
-9.01
-15.78
-11.78
Tax
NA
NA
0.00
-1.25
Provisions and contingencies
NA
NA
NA
0.00
Profit After Tax
1.77
-9.01
-15.78
-10.53
Extraordinary Items
NA
NA
0.00
0.00
Prior Period Expenses
NA
NA
NA
0.00
Other Adjustments
NA
NA
NA
0.00
Net Profit
1.77
-9.01
-15.78
-10.53
Equity Capital
79.44
79.44
79.44
79.44
Face Value (IN RS)
10
10
10
10
Reserves
0
0
Calculated EPS
0.22
-1.13
-1.98
-1.32
Calculated EPS (Annualised)
0.89
-4.53
-7.94
-5.30
No of Public Share Holdings
4983392
4983392
4983392
4983392
% of Public Share Holdings
62.73
62.73
62.73
62.73
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
7.94
3.86
1.42
-31.56
PBIDTM%
13.02
5.66
1.42
-17.15
PBDTM%
6.06
-1.14
-7.88
-20.97
PBTM%
1.42
-12.26
-16.16
-29.16
PATM%
1.42
-12.26
-16.16
-26.07
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.